DR. SRIVALLI GOPALUNI M.D. NPI 1427208990

NPI Information

  • NPI: 1427208990
  • Provider Name: DR. SRIVALLI GOPALUNI, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 605 E HOLLAND AVE
    SUITE 100
    SPOKANE, WA
    ZIP 99218
  • Phone: (509) 228-1000

Map and Directions

Get Directions

NPI Details

DR. Srivalli Gopaluni, M.D. is a hematology and oncology internal medicine in Spokane, WA with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Srivalli Gopaluni, M.D. NPI is 1427208990. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

605 E HOLLAND AVE
SUITE 100
SPOKANE, WA
ZIP 99218-225
Phone: (509) 228-1000
Fax: (509) 252-9300

The NPI 1427208990 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, docetaxel, 1 mg (HCPCS:J9171)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Refilling and maintenance of portable pump (HCPCS:96521)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Urinalysis, manual test (HCPCS:81002)

The enumeration date for this NPI number is 9/22/2008 and was last updated on 3/24/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD60263783WASHINGTONYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1G8909092MEDICARE PINWASHINGTON
2P01076548OTHERWASHINGTONRAILROAD MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.